SCHEMBL9958116

SCHEMBL9958116

CC(C)(Oc1ccc2c(c1)OCO2)C(=O)Nc1nc(OC(=O)O)cs1

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 7/20 0.52
▸ RAB9A P51151 7/20 0.52
▸ SMN1; SMN2 Q16637 7/20 0.52
▸ LMNA P02545 6/20 0.52
▸ MAPT P10636 4/20 0.52
▸ NFKB1 P19838 1/20 0.52
▸ NFKB2 Q00653 1/20 0.52
▸ RELA Q04206 1/20 0.52
▸ ADORA2A P29274 2/20 0.50
▸ KDM4E B2RXH2 2/20 0.42
▸ GAA P10253 1/20 0.42
▸ TSHR P16473 1/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ KMT2A Q03164 4/20 0.41
▸ MEN1 O00255 3/20 0.41
▸ ALOX15 P16050 1/20 0.40
▸ GSTO1 P78417 1/20 0.40
▸ ROCK1 Q13464 1/20 0.40
▸ HTT P42858 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2660820 0.86 NPC1 (0.53) NPC1RAB9ASMN1; SMN2LMNAMAPT
SCHEMBL2660279 0.83 SMN1; SMN2 (0.52) NPC1RAB9ASMN1; SMN2LMNAMAPT
SCHEMBL9957854 0.81 ADORA2A (0.53) NPC1RAB9ASMN1; SMN2LMNAMAPT
SCHEMBL2660231 0.77 ADORA2A (0.47) NPC1RAB9ASMN1; SMN2LMNAMAPT
SCHEMBL2660904 0.77 ADORA2A (0.54) NPC1RAB9ASMN1; SMN2LMNAMAPT
SCHEMBL2656339 0.76 SMN1; SMN2 (0.47) NPC1RAB9ASMN1; SMN2LMNAMAPT
SCHEMBL2661038 0.75 ADORA2A (0.56) NPC1RAB9ASMN1; SMN2LMNAMAPT
SCHEMBL2660974 0.74 GCK (0.59) NPC1RAB9ASMN1; SMN2LMNAMAPT
Ammonia Solution, Strong SCHEMBL19469522 0.71 PPARA (0.49) SMN1; SMN2LMNAMAPTKDM4EGAA
SCHEMBL28564927 0.70 LMNA (0.51) RAB9ASMN1; SMN2LMNAMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2125735-B1 2,2,2-TRI-SUBSTITUTED ACETAMIDE DERIVATIVES AS GLUCOKINASE ACTIVATORS, THEIR PROCESS AND PHARMACEUTICAL APPLICATION ADVINUS THERAPEUTICS PRIVATE LTD (IN) 2012-06-27 — — EP claimed
Send feedback